HINDGUT NEUROENDOCRINE TUMOR
Clinical trials for HINDGUT NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new HINDGUT NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for HINDGUT NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat digestive tumors
Disease control OngoingThis study is testing whether the drug abemaciclib can help control advanced digestive system neuroendocrine tumors that have spread and stopped responding to standard treatments. The drug works by blocking enzymes that tumor cells need to grow. About 20 patients with these speci…
Matched conditions: HINDGUT NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial aims to halt rare Cancer's spread
Disease control OngoingThis study is testing whether a drug called pazopanib can slow or stop the growth of carcinoid tumors that are getting worse. It compares pazopanib against a placebo (inactive pill) in 171 patients whose tumors have progressed. The main goal is to see if the drug helps patients l…
Matched conditions: HINDGUT NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC